Increasing HIV subtype diversity in canadian-born patients living in Southern Alberta, Canada

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 2, 2011, Pages

  Luft, Leeanne M ^a   Beckthold, Brenda ^a   Gill, M John ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANADA; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS SUBTYPE B; INTRAVENOUS DRUG ABUSE; LETTER; MAJOR CLINICAL STUDY; MALE; MICROBIAL DIVERSITY; PRIORITY JOURNAL; VIRUS TRANSMISSION;

ADULT; ALBERTA; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 79957961868     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821438d9     Document Type: Letter

References (37)

1. Health Canada. HIV and AIDS in Canada. Minister of Public Works and Government Services. Ottawa, Ontario, Canada: Surveillance Report to June 30, 2002. Ottawa, ON: The Canadian HIV/AIDS Clearinghouse; 2002.
2. Ottawa: Health Canada. Summary: Estimates of HIV Prevalence and Incidence in Canada, .2008. Ottawa, ON: Public Health Agency of Canada; 2008.
3. Osborn JE. HIV: the more things change, the more they stay the same. Public Health Agency of Canada. Tunney's Pasture, Ottawa, Ontario, Canada: Nat Med. 1995;1:991-993.
4. de Oliveira CF, Diaz RS, Machado DM, et al. Surveillance of HIV-1 genetic subtypes and diversity in the US blood supply. Transfusion. 2000;40:1399-1406.
5. Glauser MP, Francioli P. Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe. Eur J Clin Microbiol. 1984;3:55-58. (Pubitemid 14158819)
6. Casado C, Urtasun I, Saragosti S, et al. Different distribution of HIV type 1 genetic variants in European patients with distinct risk practices. AIDS Res Hum Retroviruses. 2000; 16:299-304. (Pubitemid 30111967)
7. Hemelaar J, Gouws E, Ghys PD, et al. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 2006;20:W13-W23. (Pubitemid 44611051)
8. Yang C, Pieniazek D, Owen SM, et al. Detection of phylogenetically diverse human immunodeficiency virus type 1 groups M and O from plasma by using highly sensitive and specific generic primers. J Clin Microbiol. 1999;37:2581-2586. (Pubitemid 29337282)
9. Thomson MM, Najera R. Increasing HIV-1 genetic diversity in Europe. J Infect Dis. 2007; 196:1120-1124. (Pubitemid 47580265)
10. Wheeler WH, Ziebell RA, Zabina H, et al. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, USd2006. AIDS. 2010; 24:1203-1212.
11. Sides TL, Akinsete O, Henry K, et al. HIV-1 subtype diversity in Minnesota. J Infect Dis. 2005;192:37-45. (Pubitemid 40863855)
12. Cartwright CP. The changing epidemiology of HIV/AIDS at a Minnesota hospital: impact of demographic change and viral diversity. J Med Virol. 2006;78(suppl 1):S19-S21. (Pubitemid 43993459)
13. Parker MM, Gordon D, Reilly A, et al. Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naive, HIV-infected individuals in New York State. AIDS Patient Care STDS. 2007;21:644-652. (Pubitemid 47525387)
14. Descamps D, Chaix ML, Montes B, et al. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. J Antimicrob Chemother. 2010;65: 2620-2627.
15. Burns FM, Arthur G, Johnson AM, et al. United Kingdom acquisition of HIV infection in African residents in London: more than previously thought. AIDS. 2009;23:262-266.
16. Parczewski M, Leszczyszyn-Pynka M, Bander D, et al. Characteristics of HIV-1 non-B subtype infections in Northwest Poland. J Med Virol. 2010;82:1306-1313.
17. Habekova M, Takacova M, Lysy J, et al. Genetic subtypes of HIV type 1 circulating in Slovakia. AIDS Res Hum Retroviruses. 2010; 26:1103-1107.
18. Toledo PV, de Carvalho DS, de Rossi SG, et al. Genetic diversity of human immunodeficiency virus-1 isolates in Parana, Brazil. Braz J Infect Dis. 2010;14:230-236.
19. Tan Y, Chan D, Chan D, et al. High genetic diversity of HIV-1 viruses in Macao, China. J Infect. 2010;61:164-172.
20. Chen JH, Wong KH, Chen Z, et al. Increased genetic diversity of HIV-1 circulating in Hong Kong. PLoS ONE. 2010;5:e12198.
21. Krentz H, Gill MJ. The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population. Health Policy. 2009; 90:296-302.
22. Osuna JP. The exclusion from the United States of aliens infected with the AIDS virus: recent developments and prospects for the future. Houst J Int Law. 1993;16:1-41.
23. Fairchild AL, Tynan EA. Policies of containment: immigration in the era of AIDS. Am J Public Health. 1994;84:2011-2022.
24. Bennett D. HIV [corrected] genetic diversity surveillance in the United States. J Infect Dis. 2005;192:4-9. (Pubitemid 40863849)
25. John-Stewart GC, Nduati RW, Rousseau CM, et al. Subtype C Is associated with increased vaginal shedding of HIV-1. J Infect Dis. 2005; 192:492-496. (Pubitemid 41023129)
26. Rao VR, Sas AR, Eugenin EA, et al. HIV-1 clade-specific differences in the induction of neuropathogenesis. J Neurosci. 2008;28: 10010-10016.
27. Kuritzkes DR. HIV-1 subtype as a determinant of disease progression. J Infect Dis. 2008;197: 638-639. (Pubitemid 351364458)
28. Keller M, Lu Y, Lalonde RG, et al. Impact of HIV-1 viral subtype on CD4+ T-cell decline and clinical outcomes in antiretroviral naive patients receiving universal healthcare. AIDS. 2009;23:731-737.
29. Church JD, Huang W, Mwatha A, et al. HIV-1 tropism and survival in vertically infected Ugandan infants. J Infect Dis. 2008;197: 1382-1388. (Pubitemid 351706461)
30. Baeten JM, Chohan B, Lavreys L, et al. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis. 2007; 195:1177-1180. (Pubitemid 46543449)
31. Church D, Gregson D, Lloyd T, et al. HIV-1 viral load multi-assay comparison of the RealTime HIV-1, COBAS TaqMan 48 v 1.0, Easy Q v1.2 and Versant v3.0 assays in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol. 2011;49:118-124.
32. Easterbrook PJ, Smith M, Mullen J, et al. Impact of HIV01 viral subtype on disease progression and response to antiretroviral therapy. J Int AIDS Soc. 2010;13:4.
33. Geretti AM, Harrison L, Green H, et al. Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy. Clin Infect Dis. 2009;48: 1296-2305.
34. Campbell TB. Are all HIV type 1 strains created equal? Clin Infect Dis. 2006;42:853-854. (Pubitemid 43363944)
35. Thomson MM, Najera R. Travel and the introduction of human immunodeficiency virus type 1 non-B subtype genetic forms into Western countries. Clin Infect Dis. 2001;32: 1732-1737. (Pubitemid 32532004)
36. Dias CF, Nunes CC, Freitas IO, et al. High prevalence and association of HIV-1 non-B subtype with specific sexual transmission risk among antiretroviral naive patients in Porto Alegre, RS, Brazil. Rev Inst Med Trop Sao Paulo. 2009;51:191-196.
37. Duncan KC, Reading C, Borwein AM, et al. HIV incidence and prevalence among Aboriginal peoples in Canada. AIDS Behav. 2011;15: 214-227.